| Date | Time | Source | Headline | Symbol | Company |
| 05/17/2024 | 5:05PM | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements | NASDAQ:MOVE | Movano Inc |
| 05/17/2024 | 4:30PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:MOVE | Movano Inc |
| 05/17/2024 | 4:30PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:MOVE | Movano Inc |
| 05/17/2024 | 4:27PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:MOVE | Movano Inc |
| 05/15/2024 | 4:31PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:MOVE | Movano Inc |
| 05/15/2024 | 4:18PM | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB | NASDAQ:MOVE | Movano Inc |
| 05/15/2024 | 4:05PM | PR Newswire (US) | Movano Health Reports Q1 2024 Financial Results and Provides Business Update | NASDAQ:MOVE | Movano Inc |
| 05/09/2024 | 8:00AM | PR Newswire (US) | Movano Health Submits Exemplary Sp02 Clinical Trial Results in Key Step Towards FDA 510(k) Clearance Decision | NASDAQ:MOVE | Movano Inc |
| 05/08/2024 | 4:29PM | Edgar (US Regulatory) | Form 424B7 - Prospectus [Rule 424(b)(7)] | NASDAQ:MOVE | Movano Inc |
| 05/08/2024 | 12:15AM | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:MOVE | Movano Inc |
| 05/06/2024 | 5:00PM | PR Newswire (US) | Movano Health to Report First Quarter 2024 Financial Results on Wednesday May 15, 2024 | NASDAQ:MOVE | Movano Inc |
| 04/05/2024 | 8:00AM | PR Newswire (US) | Movano Health Closes $24 Million Private Placement | NASDAQ:MOVE | Movano Inc |
| 04/04/2024 | 4:30PM | PR Newswire (US) | Movano Health Reports 2023 Financial Results and Provides Business Update | NASDAQ:MOVE | Movano Inc |
| 04/02/2024 | 5:01PM | PR Newswire (US) | Movano Health Announces $24 Million Private Placement | NASDAQ:MOVE | Movano Inc |
| 04/02/2024 | 5:00PM | PR Newswire (US) | Movano Health Secures Strategic Investment from Tier-One Multi-Billion Dollar Medical Device Company | NASDAQ:MOVE | Movano Inc |
| 04/02/2024 | 4:05PM | PR Newswire (US) | Movano Health to Report Fourth Quarter 2023 Financial Results on Thursday, April 4, 2024 | NASDAQ:MOVE | Movano Inc |
| 03/14/2024 | 6:31PM | PR Newswire (US) | Evie Ring's Pulse Oximeter Exceeds FDA Accuracy Guidelines in Movano Health's Second Hypoxia Trial | NASDAQ:MOVE | Movano Inc |
| 01/22/2024 | 8:00AM | PR Newswire (US) | Movano Health Announces Evie Rings Now Shipping | NASDAQ:MOVE | Movano Inc |
| 01/09/2024 | 8:00AM | PR Newswire (US) | Movano Health and ams OSRAM Collaborate to Deliver Accurate Lifestyle Monitoring Solutions for Women | NASDAQ:MOVE | Movano Inc |
| 01/08/2024 | 7:00AM | PR Newswire (US) | Evie, the First Women-Focused Health Ring, Takes 'Smart' to a New Level | NASDAQ:MOVE | Movano Inc |
| 01/04/2024 | 4:29PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:MOVE | Movano Inc |
| 01/04/2024 | 4:28PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:MOVE | Movano Inc |
| 12/18/2023 | 8:00AM | PR Newswire (US) | Movano Health Announces HSA/FSA Eligibility for its Women First Wearable, The Evie Ring | NASDAQ:MOVE | Movano Inc |
| 12/12/2023 | 12:00PM | PR Newswire (US) | Movano Health Announces Blood Pressure Partnership Forum Following Significant Response to Groundbreaking Accuracy Achievement | NASDAQ:MOVE | Movano Inc |
| 12/05/2023 | 8:00AM | PR Newswire (US) | Movano Health's Women-First Wearable, the Evie Ring, Receives 2024 CES Innovation Award | NASDAQ:MOVE | Movano Inc |
| 11/29/2023 | 9:08AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:MOVE | Movano Inc |
| 11/29/2023 | 8:00AM | PR Newswire (US) | Movano Health Announces Over $1M Black Friday Holiday Launch Results for the Evie Ring as well as Cuffless Blood Pressure Milestone Achievement | NASDAQ:MOVE | Movano Inc |
| 11/20/2023 | 8:00AM | PR Newswire (US) | Evie, the Smart Ring for Women from Movano Health, Available for Order Today | NASDAQ:MOVE | Movano Inc |
| 11/17/2023 | 10:09AM | PR Newswire (US) | Movano Health Announces Closing of $4.1 Million Public Offering Including Full Exercise of Over-Allotment Option | NASDAQ:MOVE | Movano Inc |
| 11/16/2023 | 5:24PM | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | NASDAQ:MOVE | Movano Inc |